Inventor · disambiguated record
Hari P. Miskin
Also filed as: MISKIN HARI P
3 granted patents·4 pending applications·9 citations·filing 2013–2021
62Inventor score
Files withTG THERAPEUTICS INC7
Top patents by PatentIndex Score
7 records- 0183US10966977B2Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disordersTG THERAPEUTICS INC·Filed 2017·Granted Apr 6, 2021·4 cites·20 claims
- 0278US9694071B2Combination of anti-CD20 antibody and PI3 kinase selective inhibitorTG THERAPEUTICS INC·Filed 2013·Granted Jul 4, 2017·5 cites·25 claims
- 0359US2020323981A1Combination of Anti-CD20 Antibody and PI3 Kinase Selective InhibitorTG THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0457US10729768B2Combination of anti-CD20 antibody and PI3 kinase selective inhibitorTG THERAPEUTICS INC·Filed 2017·Granted Aug 4, 2020·0 cites·35 claims
- 0555US2021169878A1Combination of anti-cd20 antibody, p13 kinase-delta selective inhibitor, and btk inhibitor to treat b-cell proliferative disordersTG THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0650US2022143026A1Triple combination to treat b-cell malignanciesTG THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0740US2019247399A1Combination of an anti-cd20 antibody, pi3 kinase-delta inhibitor, and anti-pd-1 or anti-pd-l1 antibody for treating hematological cancersTG THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hari P. Miskin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →